Verschuuren JJ - Search Results

1

IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.

Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM. Selman MH, et al. Among authors: verschuuren jj. J Proteome Res. 2011 Jan 7;10(1):143-52. doi: 10.1021/pr1004373. Epub 2010 Jul 30. J Proteome Res. 2011. PMID: 20672848

2

Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.

Verschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, Posner JB, Newsom-Davis J, Rosenfeld MR. Verschuuren JJ, et al. Neurology. 1998 Feb;50(2):475-9. doi: 10.1212/wnl.50.2.475. Neurology. 1998. PMID: 9484375

3

[Proximal muscle weakness, depressed tendon reflexes and autonomic dysfunction: the Lambert-Eaton myasthenic syndrome].

Wirtz PW, Kuks JB, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. Ned Tijdschr Geneeskd. 2001 Jan 13;145(2):57-61. Ned Tijdschr Geneeskd. 2001. PMID: 11225256 Review. Dutch.

4

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.

Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. Hum Immunol. 2001 Aug;62(8):809-13. doi: 10.1016/s0198-8859(01)00270-1. Hum Immunol. 2001. PMID: 11476904

5

Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.

Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. Clin Neurol Neurosurg. 2002 Sep;104(4):359-63. doi: 10.1016/s0303-8467(02)00054-9. Clin Neurol Neurosurg. 2002. PMID: 12140105

6

Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.

Wirtz PW, Sotodeh M, Nijnuis M, Van Doorn PA, Van Engelen BG, Hintzen RQ, De Kort PL, Kuks JB, Twijnstra A, De Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):766-8. doi: 10.1136/jnnp.73.6.766. J Neurol Neurosurg Psychiatry. 2002. PMID: 12438488 Free PMC article.

7

The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.

Wirtz PW, Nijnuis MG, Sotodeh M, Willems LN, Brahim JJ, Putter H, Wintzen AR, Verschuuren JJ; Dutch Myasthenia Study Group. Wirtz PW, et al. Among authors: verschuuren jj. J Neurol. 2003 Jun;250(6):698-701. doi: 10.1007/s00415-003-1063-7. J Neurol. 2003. PMID: 12796832

8

High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome.

Wirtz PW, Huizinga TW, Stoeken DJ, Wintzen AR, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. J Neuroimmunol. 2003 Jul;140(1-2):194-7. doi: 10.1016/s0165-5728(03)00205-4. J Neuroimmunol. 2003. PMID: 12864989

9

Decremental response of the nasalis and hypothenar muscles in myasthenia gravis.

Niks EH, Badrising UA, Verschuuren JJ, Van Dijk JG. Niks EH, et al. Among authors: verschuuren jj. Muscle Nerve. 2003 Aug;28(2):236-8. doi: 10.1002/mus.10411. Muscle Nerve. 2003. PMID: 12872330 Clinical Trial.

10

HLA-B8 in patients with the Lambert-Eaton myasthenic syndrome reduces likelihood of associated small cell lung carcinoma.

Wirtz PW, Willcox N, Roep BO, Lang B, Wintzen AR, Newsom-Davis J, Verschuuren JJ. Wirtz PW, et al. Among authors: verschuuren jj. Ann N Y Acad Sci. 2003 Sep;998:200-1. doi: 10.1196/annals.1254.021. Ann N Y Acad Sci. 2003. PMID: 14592876 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page